NEKTAR THERAPEUTICS shareholders Q2 2023

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 149 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

NEKTAR THERAPEUTICS shareholders Q2 2023
NameSharesValueWeighting ↓
Monaco Asset Management SAM 9,260,717$5,326,7641.49%
Sio Capital Management, LLC 6,995,381$4,023,7431.02%
Deep Track Capital, LP 17,973,464$10,338,3360.48%
CM Management, LLC 750,000$4310.42%
Acuitas Investments, LLC 721,493$415,0030.24%
Inspire Investing, LLC 551,556$317,2550.04%
Moloney Securities Asset Management, LLC 355,105$204,2560.04%
US Asset Management LLC 37,964$220.02%
Marquette Asset Management, LLC 148,378$85,3480.02%
Y-Intercept (Hong Kong) Ltd 312,003$179,4640.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 4,870,478$2,801,4990.02%
CTC Alternative Strategies, Ltd. 16,100$9,2610.01%
Birchview Capital, LP 28,000$16,1060.01%
TANG CAPITAL MANAGEMENT LLC 139,600$80,2980.01%
HARBOR CAPITAL ADVISORS, INC. 82,798$47,6250.01%
GSA CAPITAL PARTNERS LLP 178,489$1030.01%
ACADIAN ASSET MANAGEMENT LLC 4,396,020$2,5280.01%
OCCUDO QUANTITATIVE STRATEGIES LP 150,154$86,3690.01%
TWO SIGMA ADVISERS, LP 3,803,542$2,187,7970.01%
Maltin Wealth Management, Inc. 13,000$7,4780.01%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q2 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.